Atorvastatin Shows Limited Disease-Modifying Effects in an A53T α-Synuclein Mouse Model of Parkinson's Disease.

Wei L, Hua J, Tang S, Lei J, Li G, Wei L, Mo M

Open source

DOI
10.1007/s12640-026-00825-y
Published
2026 Sep 9
Container
Neurotoxicity research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12640-026-00825-y,
  title = {Atorvastatin Shows Limited Disease-Modifying Effects in an A53T α-Synuclein Mouse Model of Parkinson's Disease.},
  author = {Wei L and Hua J and Tang S and Lei J and Li G and Wei L and Mo M},
  year = {2026},
  journal = {Neurotoxicity research},
  doi = {10.1007/s12640-026-00825-y},
  url = {https://doi.org/10.1007/s12640-026-00825-y}
}

RIS

TY  - JOUR
TI  - Atorvastatin Shows Limited Disease-Modifying Effects in an A53T α-Synuclein Mouse Model of Parkinson's Disease.
AU  - Wei L
AU  - Hua J
AU  - Tang S
AU  - Lei J
AU  - Li G
AU  - Wei L
AU  - Mo M
PY  - 2026
JO  - Neurotoxicity research
DO  - 10.1007/s12640-026-00825-y
UR  - https://doi.org/10.1007/s12640-026-00825-y
ER  - 

APA

L, W., J, H., S, T., J, L., G, L., L, W., & M, M. (2026). Atorvastatin Shows Limited Disease-Modifying Effects in an A53T α-Synuclein Mouse Model of Parkinson's Disease.. Neurotoxicity research. https://doi.org/10.1007/s12640-026-00825-y

Source records